活动性银屑病关节炎-话题@MedSci

#活动性银屑病关节炎#

14篇内容 | 1269人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2237753, encodeId=5128223e75317, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a> <a href='/topic/show?id=4f363411d4' target=_blank style='color:#2F92EE;'>#bimekizumab#</a> <a href='/topic/show?id=13d31214458e' target=_blank style='color:#2F92EE;'>#疾病控制标准#</a>, objectTitle=Ther Adv Musculoskelet Dis：Bimekizumab单抗治疗活动性银屑病关节炎临床疾病控制标准与患者结果的关联研究, objectType=article, longId=851784, objectId=bbbd851e8433, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241118/1731922126592_8538692.jpg, objectUrl=/article/show_article.do?id=bbbd851e8433, replyNumber=0, likeNumber=8, createdTime=2024-11-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bbbd851e8433, moduleTitle=Ther Adv Musculoskelet Dis：Bimekizumab单抗治疗活动性银屑病关节炎临床疾病控制标准与患者结果的关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbbd851e8433)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1491006, encodeId=d8e714910062c, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究, objectType=article, longId=732834, objectId=ef20e328345b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef20e328345b, replyNumber=0, likeNumber=93, createdTime=2022-07-21, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef20e328345b, moduleTitle=A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef20e328345b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491005, encodeId=925c149100544, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果, objectType=article, longId=725974, objectId=3d38e2597445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d38e2597445, replyNumber=0, likeNumber=74, createdTime=2022-05-03, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d38e2597445, moduleTitle=Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d38e2597445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491004, encodeId=0b311491004d0, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果, objectType=article, longId=301767, objectId=e074301e677e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e074301e677e, replyNumber=0, likeNumber=79, createdTime=2022-03-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e074301e677e, moduleTitle=Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e074301e677e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491003, encodeId=230f149100339, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, objectType=article, longId=301742, objectId=ea63301e42f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea63301e42f2, replyNumber=0, likeNumber=100, createdTime=2022-03-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea63301e42f2, moduleTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea63301e42f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491002, encodeId=fb3914910026c, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析, objectType=article, longId=221074, objectId=c0212210e40d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0212210e40d, replyNumber=0, likeNumber=104, createdTime=2021-11-27, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0212210e40d, moduleTitle=Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0212210e40d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491001, encodeId=181e149100195, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效, objectType=article, longId=219178, objectId=43202191e830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43202191e830, replyNumber=0, likeNumber=73, createdTime=2021-10-26, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43202191e830, moduleTitle=Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43202191e830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491000, encodeId=ecd0149100061, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果, objectType=article, longId=218828, objectId=bead21882881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bead21882881, replyNumber=0, likeNumber=90, createdTime=2021-10-20, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bead21882881, moduleTitle=Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bead21882881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490999, encodeId=ac93149099907, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）, objectType=article, longId=203779, objectId=0bb5203e7985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bb5203e7985, replyNumber=0, likeNumber=87, createdTime=2020-11-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bb5203e7985, moduleTitle=欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bb5203e7985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490998, encodeId=d2bb1490998d8, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见, objectType=article, longId=202280, objectId=18ae2022800c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18ae2022800c, replyNumber=0, likeNumber=88, createdTime=2020-10-21, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18ae2022800c, moduleTitle=TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18ae2022800c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490997, encodeId=a146149099e8e, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎, objectType=article, longId=191455, objectId=80f2191455c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f2191455c6, replyNumber=0, likeNumber=110, createdTime=2020-04-06, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f2191455c6, moduleTitle=Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f2191455c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490996, encodeId=15731490996b1, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）, objectType=article, longId=141713, objectId=7d96141e13fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d96141e13fa, replyNumber=0, likeNumber=103, createdTime=2018-06-28, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d96141e13fa, moduleTitle=FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d96141e13fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490995, encodeId=b9e414909950d, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展, objectType=article, longId=132812, objectId=122f1328125d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122f1328125d, replyNumber=0, likeNumber=85, createdTime=2018-03-20, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122f1328125d, moduleTitle=Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122f1328125d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490994, encodeId=6c2b14909944f, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性, objectType=article, longId=108861, objectId=02791088610f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02791088610f, replyNumber=0, likeNumber=74, createdTime=2017-08-17, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02791088610f, moduleTitle=Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02791088610f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1490993, encodeId=b5b2149099336, content=<a href='/topic/show?id=779c6518253' target=_blank style='color:#2F92EE;'>#活动性银屑病关节炎#</a>, objectTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, objectType=article, longId=79983, objectId=a20ce9983ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a20ce9983ea, replyNumber=0, likeNumber=74, createdTime=2016-10-14, rootId=0, userName=nian.wang1985, userId=ef878855116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a20ce9983ea, moduleTitle=2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a20ce9983ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

活动性银屑病关节炎

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎# #bimekizumab# #疾病控制标准#

Ther Adv Musculoskelet Dis：Bimekizumab单抗治疗活动性银屑病关节炎临床疾病控制标准与患者结果的关联研究

2024-11-19发表于陕西省

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

A&R：比美吉珠单抗治疗活动性银屑病关节炎的安全性和有效性研究

2022-07-21

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：瑞莎珠单抗治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1试验24周结果

2022-05-03

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Arthritis Rheumatol：利桑珠单抗治疗活动性银屑病关节炎的疗效和安全性：3期KEEPsAKE 2试验的24周结果

2022-03-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效

2022-03-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：瑞莎珠单抗治疗对活动性银屑病关节炎的疗效和安全性分析

2021-11-27

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Lancet Rheumatology：Guselkumab对活动性银屑病关节炎和骶髂关节炎患者中轴受累的疗效

2021-10-26

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：替拉珠单抗治疗活动性银屑病关节炎的疗效和安全性——随机、双盲、安慰剂对照、多剂量、52周的IIb期研究结果

2021-10-20

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

欧盟委员会批准了TREMFYA®（guselkumab）治疗活动性银屑病关节炎（PsA）

2020-11-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

TREMFYA（guselkumab）治疗活动性银屑病关节炎（PsA）：已获得CHMP的积极意见

2020-10-21

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Lancet：白细胞介素23单抗Guselkumab治疗活动性银屑病关节炎

2020-04-06

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

FDA批准Cosentyx治疗关节活动性银屑病关节炎（PsA）

2018-06-28

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Ann Rheum Dis：苏金单抗改善活动性银屑病关节炎的症状并抑制影像学进展

2018-03-20

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

Arthritis Rheumatol：活动性银屑病关节炎静脉注射戈利木单抗的安全性和有效性

2017-08-17

nian.wang1985 (审核中...)

前往app查看评论内容

#活动性银屑病关节炎#

2015NICE技术评估指南——阿普斯特治疗活动性银屑病关节炎（TA372）发布

2016-10-14

科室
- - 订阅+
  - 更多科室
工具
服务